<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/15/3059" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/15/3059/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/15/3059/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_3059"><akn:num>3059</akn:num><akn:heading>Unfair or deceptive acts or practices</akn:heading><akn:content><akn:p>§ 3059. Unfair or deceptive acts or practices
The sale of a covered horse, or of any other horse in anticipation of its future participation in a covered race, shall be considered an unfair or deceptive act or practice in or affecting commerce under section 45(a) of this title if the seller—(1) knows or has reason to know the horse has been administered—(A) a bisphosphonate prior to the horse’s fourth birthday; or

(B) any other substance or method the Authority determines has a long-term degrading effect on the soundness of the covered horse; and


(2) fails to disclose to the buyer the administration of the bisphosphonate or other substance or method described in paragraph (1)(B).

(Pub. L. 116–260, div. FF, title XII, § 1210, Dec. 27, 2020, 134 Stat. 3274.)</akn:p></akn:content><akn:subsection eId="subsec_3059_1"><akn:num>(1)</akn:num><akn:content><akn:p>(1) knows or has reason to know the horse has been administered—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_3059_2"><akn:num>(2)</akn:num><akn:content><akn:p>(2) fails to disclose to the buyer the administration of the bisphosphonate or other substance or method described in paragraph (1)(B).</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>